L & S Advisors Inc Moderna, Inc. Transaction History

L & S Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $47,320 - $71,342	404 Added 22.32%	2,214 $316,000
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $93,201 - $173,231	-737 Reduced 28.94%	1,810 $312,000
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $74,746 - $121,976	-331 Reduced 11.5%	2,547 $647,000
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $2.24 Million - $4.88 Million	-10,081 Reduced 77.79%	2,878 $1.11 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $1.01 Million - $1.83 Million	7,801 Added 151.24%	12,959 $3.05 Million
Q1 2021 May 10, 2021	SELL	$109.18 - $185.98 $2.53 Million - $4.31 Million	-23,169 Reduced 81.79%	5,158 $675,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $1.15 Million - $2.96 Million	-17,444 Reduced 38.11%	28,327 $2.96 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $454,771 - $793,799	8,369 Added 22.38%	45,771 $3.24 Million
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $663,243 - $1.79 Million	-22,354 Reduced 37.41%	37,402 $2.4 Million
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $1.06 Million - $1.89 Million	59,756 New	59,756 $1.79 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.